Ceftazidime Market: By Disease Condition (Meningitis, Pneumonia, Sepsis, Urinary Tract Infections, Joint Infections, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Geography

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Ceftazidime Market estimated to be valued US$ XX Mn in 2021 and poised to grow at significant CAGR over 2022-2028 due to their wide spread usage in the treatment of intra-abdominal, skin and soft tissue, as well as obstetric and gynecological infections and increasing prevalence of various infections are the major factors that are driving the growth of the ceftazidime market. Moreover, implementation of government initiatives, technological advancements and rise in research and developmental activities and product innovations fuels the growth of the market. Additionally, robust development of the healthcare sector and pharmaceutical industry and expanding patient base across the globe to boost the growth of the Ceftazidime market. Also, rising concerns among the patient is propelling the manufacturers to conduct researches with regards to the antibiotics. Global ceftazidime market is surging owing to launch of innovative products in different markets to expand the portfolio and strengthen their position in the market. For instance, in March 2017, Pfizer Inc. announced that Zavicefta, a novel combination antibiotic for the treatment of patients with certain confirmed or suspected Gram-negative bacterial infections requiring hospitalization, is now available in the U.K. and Germany. For instance, Wockhardt has received approval from the United States Food & Drug Administration (US FDA) for marketing the injections containing 1 Gm/Vial Ceftazidime, which is used for treating various kinds of infections.  

Global Ceftazidime Market Summary

Study Period

2023-29

Base Year

2022

CAGR

X%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Growth

Prevalence of bacterial infections has been raised dramatically in the past years. According to WHO, Sepsis is estimated to affect more than 30 million people worldwide every year, potentially leading to 6 million deaths. The burden of sepsis is most likely highest in low- and middle- income countries. Moreover, increasing population across the world coupled with rise in infectious diseases are expected to fuel the growth of the market over the forecasted years.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2017 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Ceftazidime Market Segmentation

Disease Condition
  • Meningitis
  • Pneumonia
  • Gynecological Infections
  • Sepsis
  • Urinary Tract Infections
  • Joint Infections
  • Pseudomonas Aeruginosa infection
  • Others
Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Geography
North America
  • US
  • Canada
Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe
Asia-Pacific
  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific
Latin America
  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America
Middle East and Africa (MEA)
  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  1. Executive Summary
  2. Global Ceftazidime Market Introduction
    • Global Ceftazidime Market – Taxonomy
    • Global Ceftazidime Market –Definitions
      • By Disease Condition
      • By Distribution Channel
      • By Region
  1. Global Ceftazidime Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Ceftazidime Market Dynamics – Factors Impact Analysis
  2. Global Ceftazidime Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
    • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Ceftazidime Market Forecast, By Disease Condition, 2014 - 2018 and Forecast, 2019 - 2025
    • Meningitis
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Pneumonia
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Gynecological Infections
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Sepsis
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Urinary Tract Infections
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Pseudomonas Aeruginosa Infection
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Joint Infections
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Ceftazidime Market Forecast, By Distribution Channel, 2014 - 2018 and Forecast, 2019 - 2025
    • Hospital Pharmacy
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacy
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacy
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Ceftazidime Market Forecast, By Region, 2014 - 2018 and Forecast, 2019 - 2025
    • North America
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia Pacific
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • The Middle East & Africa
      • Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Ceftazidime Market - Opportunity Analysis Index, By Disease Condition, By Distribution Channel, and Region, 2019 - 2025
  2. North America Ceftazidime Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
    • Disease Condition Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Meningitis
      • Pneumonia
      • Gynecological Infections
      • Sepsis
      • Urinary Tract Infections
      • Pseudomonas Aeruginosa Infection
      • Joint Infections
      • Others
    • Distribution Channel Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Ceftazidime Market - Opportunity Analysis Index, By Disease Condition, By Distribution Channel, and Country, 2019 - 2025
    • North America Ceftazidime Market Dynamics – Trends
  3. Europe Ceftazidime Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
    • Disease Condition Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Meningitis
      • Pneumonia
      • Gynecological Infections
      • Sepsis
      • Urinary Tract Infections
      • Pseudomonas Aeruginosa Infection
      • Joint Infections
      • Others
    • Distribution Channel Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Europe Ceftazidime Market - Opportunity Analysis Index, By Disease Condition, By Distribution Channel, and Country, 2019 - 2025
    • Europe Ceftazidime Market Dynamics – Trends
  4. Asia Pacific Ceftazidime Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
    • Disease Condition Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Meningitis
      • Pneumonia
      • Gynecological Infections
      • Sepsis
      • Urinary Tract Infections
      • Pseudomonas Aeruginosa Infection
      • Joint Infections
      • Others
    • Distribution Channel Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • China
      • Japan
      • India
      • ASEAN Counties
      • Philippines
      • Rest of Asia Pacific
    • Asia Pacific Ceftazidime Market - Opportunity Analysis Index, By Disease Condition, By Distribution Channel, and Country, 2019 - 2025
    • Asia Pacific Ceftazidime Market Dynamics – Trends
  5. Latin America Ceftazidime Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
    • Disease Condition Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Meningitis
      • Pneumonia
      • Gynecological Infections
      • Sepsis
      • Urinary Tract Infections
      • Pseudomonas Aeruginosa Infection
      • Joint Infections
      • Others
    • Distribution Channel Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Mexico
      • Brazil
      • Argentina
      • Chile
      • Rest of Latin America
    • Latin America Ceftazidime Market - Opportunity Analysis Index, By Disease Condition, By Distribution Channel, and Country, 2019 - 2025
    • Latin America Ceftazidime Market Dynamics – Trends
  6. Middle East and Africa Ceftazidime Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
    • Disease Condition Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Meningitis
      • Pneumonia
      • Gynecological Infections
      • Sepsis
      • Urinary Tract Infections
      • Pseudomonas Aeruginosa Infection
      • Joint Infections
      • Others
    • Distribution Channel Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • GCC Countries
      • South Africa
      • Saudi Arabia
      • Turkey
      • Rest of MEA
    • Middle East and Africa Ceftazidime Market - Opportunity Analysis Index, By Disease Condition, By Distribution Channel, and Country, 2019 - 2025
    • Middle East and Africa Ceftazidime Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
      • Covis Pharma
      • DAWNRAYS
      • Hisun
      • CNCM
      • QILU
      • YONGNING
      • WOCK HARDT
      • HOSPIRA
      • ACS Dobfar
      • CSPC
      • HGPF
  8. Research Methodology
  9. Key Assumptions and Acronyms
  • Covis Pharma
  • DAWNRAYS
  • Hisun
  • CNCM
  • QILU
  • YONGNING
  • WOCK HARDT
  • HOSPIRA
  • ACS Dobfar
  • CSPC
  • HGPF